Status:
COMPLETED
Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension
Lead Sponsor:
Allergan
Conditions:
Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This Study will evaluate the safety and efficacy of brimonidine in patients with glaucoma or ocular hypertension
Eligibility Criteria
Inclusion
- ocular hypertension or glaucoma in both eyes
- currently treated with brimonidine
- requires IOP-lowering therapy in both eyes
Exclusion
- uncontrolled systemic disease
- known allergy or sensitivity to brimonidine
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2006
Estimated Enrollment :
207 Patients enrolled
Trial Details
Trial ID
NCT00168363
Start Date
January 1 2005
End Date
August 1 2006
Last Update
May 30 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.